Artiva Biotherapeutics (ARTV) Other Working Capital Changes (2023)

Artiva Biotherapeutics (ARTV) has 4 years of Other Working Capital Changes data on file, last reported at -$2.6 million in Q1 2026.

• On a quarterly basis, Other Working Capital Changes fell 451.07% year-over-year to -$2.6 million in Q1 2026; TTM through Mar 2026 was -$1.8 million, a 203.93% decrease from a year earlier, with the FY2025 full-year figure at $1.5 million, down 21.93% from the prior year.
• Other Working Capital Changes for Q4 2023 stood at -$1.3 million, up from -$23.7 million in the prior quarter.
• Over the last five years, Other Working Capital Changes for ARTV reached as high as $2.9 million in Q2 2025 and fell as low as -$2.6 million in Q1 2026.
• Historically, Other Working Capital Changes has averaged $129090.9 across 4 years, with a median of -$176000.0 in 2024.
• On a YoY basis, Other Working Capital Changes climbed as much as 1067.57% in 2025 and fell as far as 971.59% in 2025.
• Year by year, Other Working Capital Changes stood at -$218000.0 in 2023, then advanced by 19.27% to -$176000.0 in 2024, then plunged by 971.59% to -$1.9 million in 2025, then sank by 39.61% to -$2.6 million in 2026.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were -$2.6 million in Q1 2026, -$1.9 million in Q4 2025, and -$194000.0 in Q3 2025.